The molecular bases of training adaptation

Sports Medicine

Volumn 37, Issue 9, 2007, Pages 737-763

  Coffey, Vernon G ^a   Hawley, John A ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; ADENOSINE TRIPHOSPHATASE; AMINO ACID; CALCIUM; ELONGATION FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P70; SOMATOMEDIN RECEPTOR;

BIOGENESIS; CALCIUM SIGNALING; DNA REPLICATION; ENDURANCE; EXERCISE; EXERCISE INTENSITY; EXERCISE TOLERANCE; GENE EXPRESSION; GENE SEQUENCE; HOMEOSTASIS; HUMAN; MECHANOTRANSDUCTION; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRAINING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; EXERCISE; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; SIGNAL TRANSDUCTION;

EID: 34548371839     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200737090-00001     Document Type: Review

References (281)

1. Bouchard C, Malina R, Pérusse L, editors. On the horizon: molecular biology: a new vista for exercise physiology. In: Genetics of fitness and physical performance. Champaign (IL): Human Kinetics, 1997: 970-1050
2. Izquierdo M, Ibanez J, Hakkinen K, et al. Maximal strength and power, muscle mass, endurance and serum hormones in weightlifters and road cyclists. J Sports Sci 2004; 22 (5): 465-78
3. Mahoney DJ, Parise G, Melov S, et al. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 2005; 19 (11): 1498-500
4. Bickel CS, Slade J, Mahoney E, et al. Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise. J Appl Physiol 2005; 98 (2): 482-8
5. Yang Y, Creer A, Jemiolo B, et al. Time course of myogenic and metabolic gene expression in response to acute exercise in human skeletal muscle. J Appl Physiol 2005; 98 (5): 1745-52
6. Pilegaard H, Ordway GA, Saltin B, et al. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 2000; 279: E806-14
7. Booth FW, Baldwin KM. Muscle plasticity: energy demand and supply processes. In: Rowell LB, Shepherd JT, editors. Handbook of physiology. Section 12. Exercise: regulation and integration of multiple systems. New York: Oxford University Press, 1996: 1075-123
8. Irrcher I, Adhihetty PJ, Joseph AM, et al. Regulation of mitochondrial biogenesis in muscle by endurance exercise. Sports Med 2003; 33 (11): 783-93
9. Zierath JR, Hawley JA. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol 2004; 2 (10): e348
10. Holloszy JO, Rennie MJ, Hickson RC, et al. Physiological consequences of the biochemical adaptations to endurance exercise. Ann N Y Acad Sci 1977; 301: 440-50
11. Rennie MJ, Wackerhage H, Spangenburg EE, et al. Control of the size of the human muscle mass. Ann Rev Physiol 2004; 66: 799-828
12. Häkkinen K. Neuromuscular and hormonal adaptations during strength and power training: a review. J Sports Med Phys Fitness 1989; 29 (1): 9-26
13. Ingalls CP. Nature vs nurture: can exercise really alter fibre type composition in human skeletal muscle. J Appl Physiol 2004; 97 (5): 1591-2
14. Williams RS, Neufer PD. Regulation of gene expression in skeletal muscle by contractile activity. In: Rowell LB, Shepherd JT, editors. Handbook of physiology. Section 12. Exercise: regulation and integration of multiple systems. New York: Oxford University Press, 1996: 1124-150
15. Alenghat FJ, Ingber DE. Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE 2002; (119): PE6
16. Kumar A, Chaudhry I, Reid MB, et al. Distinct signaling pathways are activated in response to mechanical stress applied axially and transversely to skeletal muscle fibers. J Biol Chem 2002; 277 (48): 46493-503
17. Hornberger TA, Armstrong DD, Koh TJ, et al. Intracellular signaling specificity in response to uniaxial vs multiaxial stretch: implications for mechanotransduction. Am J Physiol Cell Physiol 2005; 288 (1): C185-94
18. Spriet LL. Regulation of skeletal muscle fat oxidation during exercise in humans. Med Sci Sports Exerc 2002; 34 (9): 1477-84
19. Schertzer JD, Green HJ, Fowles JR, et al. Effects of prolonged exercise and recovery on sarcoplasmic reticulum Ca2+ cycling properties in rat muscle homogenates. Acta Physiol Scand 2004; 180: 195-208
20. Matsunaga S, Inashima S, Tsuchimochi H, et al. Altered sarcoplasmic reticulum function in rat diaphragm after high-intensity exercise. Acta Physiol Scand 2002; 176: 227-32
21. Holloway GP, Green HJ, Duhamel TA, et al. Muscle sarcoplasmic reticulum Ca2+ cycling adaptations during 16h of heavy intermittent cycle exercise. J Appl Physiol 2005; 99 (3): 836-43
22. S6k correlates with increased skeletal muscle mass following resistance exercise. Am J Physiol Cell Physiol 1999; 276 (45): C120-7
23. Chin ER. Role of Ca2+/calmodulin-dependent kinases in skeletal muscle plasticity. J Appl Physiol 2005; 99 (2): 414-23
24. Smith MA, Reid MB. Redox modulation of contractile function in respiratory and limb skeletal muscle. Resp Physiol Neurobiol New Direct Exerc Physiol 2006; 151 (2-3): 229-41
25. Arbogast S, Reid MB. Oxidant activity in skeletal muscle fibers is influenced by temperature, CO2 level, and muscle-derived nitric oxide. Am J Physiol Regul Integr Comp Physiol 2004; 287 (4): R698-705
26. Carrero P, Okamoto K, Coumailleau P, et al. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor α. Mol Cell Biol 2000; 20 (1): 402-15
27. Jindra M, Gaziova I, Uhlirova M, et al. Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila. EMBO J 2004; 23 (17): 3538-47
28. Hawley JA, Zierath J. Integration of metabolic and mitogenic signal transduction in skeletal muscle. Exerc Sport Sci Rev 2004; 32 (1): 4-8
29. Sakamoto K, Goodyear LJ. Exercise effects on muscle insulin signaling and action (invited review): intracellular signaling in contracting skeletal muscle. J Appl Physiol 2002; 93 (1): 369-83
30. Ferguson RA, Ball D, Krustrup P, et al. Muscle oxygen uptake and energy turnover during dynamic exercise at different contraction frequencies in humans. J Physiol (Lond) 2001; 536 (1): 261-71
31. Ivy JL, Chi MM, Hintz CS, et al. Progressive metabolite changes in individual human muscle fibers with increasing work rates. Am J Physiol Cell Physiol 1987; 252 (6): C630-9
32. Krustrup P, Ferguson RA, Kjar M, et al. ATP and heat production in human skeletal muscle during dynamic exercise: higher efficiency of anaerobic than aerobic ATP resynthesis. J Physiol (Lond) 2003; 549 (1): 255-69
33. Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology 2006; 21 (1): 48-60
34. Aschenbach WG, Sakamoto K, Goodyear LJ. 5′-Adenosine monophosphate-activated protein kinase, metabolism and exercise. Sports Med 2004; 34 (2): 91-103
35. Jorgensen SB, Richter EA, Wojtaszewski JFP. Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol (Lond) 2006; 574 (1): 17-31
36. Hayashi T, Hirshman M, Kurth E, et al. Evidence for 5′-AMP- activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47 (8): 1369-73
37. Musi N, Hayashi T, Fujii N, et al. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 2001; 280 (5): E677-84
38. Nakano M, Hamada T, Hayashi T, et al. Isoform-specific activation of 5′adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4- carboxamide-1-α-d-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle. Metabolism 2006; 55 (3): 300-8
39. Kaushik VK, Young ME, Dean DJ, et al. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 2001; 281 (2): E335-40
40. Lee JL, Kim M, Park H-S, et al. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARa and PGC-1. Biochem Biophys Res Commun 2006; 340: 291-5
41. Terada S, Kawanaka K, Goto M, et al. Effects of high-intensity intermittent swimming on PGC-1a protein expression in rat skeletal muscle. Acta Physiol Scand 2005; 184 (1): 59-65
42. Jorgensen SB, Wojtaszewski JFP, Viollet B, et al. Effects of α-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J 2005; 19 (9): 1146-8
43. Bolster DR, Crozier SJ, Kimball SR, et al. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277 (27): 23977-80
44. Toyoda T, Tanaka S, Ebihara K, et al. Low-intensity contraction activates the α1-isoform of 5′-AMP-activated protein kinase in rat skeletal muscle. Am J Physiol Endocrinol Metab 2006; 290 (3): E583-90
45. Wojtaszewski JFP, Birk JB, Frosig C, et al. 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol (Lond) 2005; 564 (2): 563-73
46. Atherton PJ, Babraj JA, Smith K, et al. Selective activation of AMPK-PGC-1α; or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J 2005; 19 (7): 786-8
47. Durante PE, Mustard KJ, Park S-H, et al. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am J Physiol Endocrinol Metab 2002; 283 (1): E178-86
48. Frøsig C, Jørgensen SB, Hardie DG, et al. 5′-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 2004; 286: E411-7
49. Hurst D, Taylor EB, Cline TD, et al. AMP-activated protein kinase activity and phosphorylation of AMP-activated protein kinase in contracting muscle of sedentary and endurance-trained rats. Am J Physiol Endocrinol Metab 2005; 289 (4): E710-15
50. McConell GK, Lee-Young RS, Chen Z-P, et al. Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen. J Physiol (Lond) 2005; 568 (2): 665-76
51. Nielsen JN, Mustard KJW, Graham DA, et al. 5′-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 2003; 94 (2): 631-41
52. Taylor EB, Lamb JD, Hurst RW, et al. Endurance training increases skeletal muscle LKB1 and PGC-1α protein abundance: effects of time and intensity. Am J Physiol Endocrinol Metab 2005; 289 (6): E960-8
53. Yu M, Stepto NK, Chibalin AV, et al. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol 2003; 546 (2): 327-35
54. Rasmussen BB, Winder WW. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 1997; 83 (4): 1104-9
55. Chen Z-P, Stephens TJ, Murthy S, et al. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 2003; 52 (9): 2205-12
56. Wadley GD, Lee-Young RS, Canny BJ, et al. Effect of exercise intensity and hypoxia on skeletal muscle AMPK signaling and substrate metabolism in humans. Am J Physiol Endocrinol Metab 2006; 290 (4): E694-702
57. Clark SA, Chen Z-P, Murphy KT, et al. Intensified exercise training does not alter AMPK signaling in human skeletal muscle. Am J Physiol Endocrinol Metab 2004; 286 (5): E737-43
58. Chen Z-P, McConell GK, Michell BJ, et al. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 2000; 279 (5): E1202-6
59. Dreyer HC, Fujita S, Cadenas JG, et al. Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol (Lond) 2006; 576 (Pt 2): 613-24
60. Koopman R, Zorenc AHG, Gransier RJJ, et al. Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers. Am J Physiol Endocrinol Metab 2006; 290 (6): E1245-52
61. Coffey VG, Zhong Z, Shield A, et al. Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans. FASEB J 2005; 20 (1): 190-2
62. Rose AJ, Hargreaves M. Exercise increases Ca2+-calmodulin-dependent protein kinase II activity in human skeletal muscle. J Physiol (Lond) 2003; 553 (1): 303-9
63. Wu H, Kanatous SB, Thurmond FA, et al. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 2002; 296 (5566): 349-52
64. Fluck M, Waxham MN, Hamilton MT, et al. Skeletal muscle Ca2+-independent kinase activity increases during either hypertrophy or running. J Appl Physiol 2000; 88 (1): 352-8
65. Rose AJ, Kiens B, Richter EA. Ca2+-calmodulin dependent protein kinase expression and signalling in skeletal muscle during exercise. J Physiol (Lond) 2006; 574 (Pt 3): 889-903
66. Liu Y, Shen T, Randall WR, et al. Signaling pathways in activity-dependent fiber type plasticity in adult skeletal muscle. J Muscle Res Cell Motil 2005; 26 (1): 13-21
67. Michel RN, Dunn SE, Chin ER. Calcineurin and skeletal muscle growth. Proc Nutr Soc 2004; 63 (2): 341-9
68. Sakuma K, Nishikawa J, Nakao R, et al. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol 2003; 105 (3): 271-80
69. Musaro A, McCullagh KJA, Naya FJ, et al. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999; 400 (6744): 581-5
70. Dunn SE, Burns JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 1999; 274 (31): 21908-12
71. Scicchitano BM, Spath L, Musaro A, et al. Vasopressin-dependent myogenic cell differentiation is mediated by both Ca2+/calmodulin-dependent kinase and calcineurin pathways. Mol Biol Cell 2005; 16 (8): 3632-41
72. Dunn SE, Chin ER, Michel RN. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth. J Cell Biol 2000; 151 (3): 663-72
73. Naya FJ, Mercer B, Shelton J, et al. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 2000; 275 (7): 4545-8
74. Parsons SA, Millay DP, Wilkins BJ, et al. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 2004; 279 (25): 26192-200
75. Talmadge R, Otis J, Rittler M, et al. Calcineurin activation influences muscle phenotype in a muscle-specific fashion. BMC Cell Biol 2004; 5: 28
76. Wu H, Naya F, McKinsey T, et al. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 2000; 19 (9): 1963-73
77. Chin ER, Olson EN, Richardson JA, et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Gene Dev 1998; 12 (16): 2499-509
78. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005; 37 (10): 1974-84
79. Taniguchi C, Emanuelli B, Kahn C. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7 (2): 85-96
80. Vandenburgh HH, Karlisch P, Shansky J, et al. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am J Physiol Cell Physiol 1991; 260 (3): C475-84
81. Latres E, Amini AR, Amini AA, et al. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 2005; 280 (4): 2737-44
82. Stitt TN, Drujan D, Clarke BA, et al. The IGF/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14: 395-403
83. Chakravarthy MV, Davis BS, Booth FW. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 2000; 89: 1365-79
84. Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001; 3: 1009-13
85. Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med 2003; 9 (8): 344-50
86. Nader GA. Molecular determinants of skeletal muscle mass: getting the 'AKT' together. Int J Biochem Cell Biol 2005; 37 (10): 1985-96
87. Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307 (5712): 1098-101
88. Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001; 3: 1014-9
89. Bruss MD, Arias EB, Lienhard GE, et al. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 2005; 54 (1): 41-50
90. Cai S-L, Tee AR, Short JD, et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 2006; 173 (2): 279-89
91. Inoki K, Li Y, Zhu T, et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4 (9): 648-57
92. Nader GA, McLoughlin TJ, Esser KA. mTOR function in exerskeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators. Am J Physiol Cell Physiol 2005; 289 (6): C1457-65
93. Lai K-MV, Gonzalez M, Poueymirou WT, et al. Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 2004; 24 (21): 9295-304
94. Hahn-Windgassen A, Nogueira V, Chen C-C, et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005; 280 (37): 32081-9
95. Vyas DR, Spangenburg EE, Abraha TW, et al. GSK-3β negatively regulates skeletal myotube hypertrophy. Am J Physiol Cell Physiol 2002; 283 (2): C545-51
96. Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated down-stream signaling. PNAS 2002; 99 (21): 13571-6
97. Rena G, Woods YL, Prescott AR, et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 2002; 21 (9): 2263-71
98. Bolster DR, Kubica N, Crozier SJ, et al. Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle. J Physiol (Lond) 2003; 553 (1): 213-20
99. Wilson C, Hargreaves M, Howlett KF. Exercise does not alter subcellular localization, but increases phosphorylation of insulin-signaling proteins in human skeletal muscle. Am J Physiol Endocrinol Metab 2006; 290 (2): E341-6
100. Sakamoto K, Arnolds DEW, Ekberg I, et al. Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun 2004; 319 (2): 419-25
101. Thorell A, Hirshman MF, Nygren J, et al. Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol Endocrinol Metab 1999; 277 (4): E733-41
102. Widegren U, Jiang XJ, Krook A, et al. Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J 1998; 12: 1379-89
103. Creer A, Gallagher P, Slivka D, et al. Influence of muscle glycogen availability on ERK1/2 and Akt signaling after resistance exercise in human skeletal muscle. J Appl Physiol 2005; 99 (3): 950-6
104. Leger B, Cartoni R, Praz M, et al. Akt signalling through GSK-3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol (Lond) 2006; 576 (Pt 3): 923-33
105. Eliasson J, Elfegoun T, Nilsson J, et al. Maximal lengthening contractions increase p70S6 kinase phosphorylation in human skeletal muscle in the absence of nutritional supply. Am J Physiol Endocrinol Metab 2006; 291 (6): E1197-205
106. Williamson DL, Kubica N, Kimball SR, et al. Exercise-induced alterations in extracellular signal-regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle. J Physiol (Lond) 2006; 573 (2): 497-510
107. Reynolds TH, Reid P, Larkin LM, et al. Effects of aerobic exercise training on the protein kinase B (PKB)/mammalian target of rapamycin (mTOR) signaling pathway in aged skeletal muscle. Exp Gerontol 2004; 39 (3): 379-85
108. Krisan AD, Collins DE, Crain AM, et al. Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle. J Appl Physiol 2004; 96 (5): 1691-700
109. Sakamoto K, Aschenbach WG, Hirshman MF, et al. Akt signaling in skeletal muscle: regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 2003; 285 (5): E1081-8
110. Markuns JF, Wojtaszewski JFP, Goodyear LJ. Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle. J Biol Chem 1999; 274 (35): 24896-900
111. Wojtaszewski JFP, Higaki Y, Hirshman MF, et al. Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin Invest 1999; 104 (9): 1257-64
112. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005; 17 (6): 596-603
113. Kim D-H, Sarbassov DD, Ali SM, et al. G[β]L, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 2003; 11 (4): 895-904
114. Sarbassov DD, Ali SM, Sengupta S, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006; 22 (2): 159-68
115. Park I-H, Erbay E, Nuzzi P, et al. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Exp Cell Res 2005; 309 (1): 211-9
116. Sarbassov DD, Ali SM, Kim D-H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14 (14): 1296-302
117. Wang X, Beugnet A, Murakami M, et al. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 2005; 25 (7): 2558-72
118. Manning BD, Cantley LC. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 2003; 28 (11): 573-6
119. Garami A, Zwartkruis FJT, Nobukuni T, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003; 11 (6): 1457-66
120. Ohanna M, Sobering AK, Lapointe T, et al. Atrophy of S6K1-/-skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol 2005; 7 (3): 286-94
121. Ali SM, Sabatini DM. Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site. J Biol Chem 2005; 280 (20): 19445-8
122. Ruvinsky I, Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006; 31 (6): 342-8
123. Thomson DM, Gordon SE. Impaired overload-induced muscle growth is associated with diminished translational signaling in aged rat fast-twitch skeletal muscle. J Physiol (Lond) 2006; 574 (Pt 1): 291-305
124. Reynolds TH IV, Bodine SC, et al. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 2002; 277 (20): 17657-62
125. Parkington JD, LeBrasseur NK, Siebert AP, et al. Contraction-mediated mTOR, p70S6k, and ERK1/2 phosphorylation in aged skeletal muscle. J Appl Physiol 2004; 97 (1): 243-8
126. Parkington JD, Siebert AP, LeBrasseur NK, et al. Differential activation of mTOR signaling by contractile activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2003; 285 (5): R1086-90
127. Schieke SM, Phillips D, McCoy JP Jr, et al. The mTOR pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006; 281 (37): 27643-52
128. Bolster DR, Kimball SR, Jefferson LS. Translational control mechanisms modulate skeletal muscle gene expression during hypertrophy. Exerc Sport Sci Rev 2003; 31 (3): 111-6
129. Shima H, Pende M, Chen Y, et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998; 17 (22): 6649-59
130. Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005; 433 (7025): 477-80
131. Nader GA, Esser KA. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol 2001; 90: 1936-42
132. Karlsson HKR, Nilsson P-A, Nilsson J, et al. Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise. Am J Physiol Endocrinol Metab 2004; 287 (1): E1-7
133. Kubica N, Bolster DR, Farrell PA, et al. Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bε mRNA in a mammalian target of rapamycin-dependent manner. J Biol Chem 2005; 280 (9): 7570-80
134. Hornberger TA, Mateja RD, Chin ER, et al. Aging does not alter the mechanosensitivity of the p38, p70S6k, and JNK2 signaling pathways in skeletal muscle. J Appl Physiol 2005; 98 (4): 1562-6
135. Spangenburg EE, McBride TA. Inhibition of stretch-activated channels during eccentric muscle contraction attenuates p70S6K activation. J Appl Physiol 2006; 100 (1): 129-35
136. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287 (4): C834-43
137. Fernandez-Celemin L, Pasko N, Blomart V, et al. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-α. Am J Physiol Endocrinol Metab 2002; 283 (6): E1279-90
138. Garcia-Martinez C, Agell N, Llovera M, et al. Tumour necrosis factor-[α] increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett 1993; 323 (3): 211-4
139. Lang CH, Krawiec BJ, Huber D, et al. Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006; 290 (4): R963-72
140. Williamson DL, Kimball SR, Jefferson LS. Acute treatment with TNF-α attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. Am J Physiol Endocrinol Metab 2005; 289 (1): E95-104
141. Langen RCJ, Van Der Velden JLJ, Schols AMWJ, et al. Tumor necrosis factor-α inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 2004; 18 (2): 227-37
142. Vashisht Gopal Y, Arora T, Van Dyke M. Tumor necrosis factor-α depletes histone deacetylase 1 protein through IKK2. EMBO Rep 2006; 7 (3): 291-6
143. Del Aguila LF, Claffey KP, Kirwan JP. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol Endocrinol Metab 1999; 276 (5): E849-55
144. Plomgaard P, Bouzakri K, Krogh-Madsen R, et al. Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005; 54 (10): 2939-45
145. de Alvaro C, Teruel T, Hernandez R, et al. Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner. J Biol Chem 2004; 279 (17): 17070-8
146. Li Y-P, Lecker SH, Chen Y, et al. TNF-α increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 2003; 17 (9): 1048-57
147. Li Y-P, Chen Y, John J, et al. TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005; 19 (3): 362-70
148. Lang CH, Frost RA, Nairn AC, et al. TNF-α impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 2002; 282 (2): E336-47
149. Sriwijitkamol A, Christ-Roberts C, Berria R, et al. Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 2006; 55 (3): 760-7
150. Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515 (1): 287-91
151. Del Aguila LF, Krishnan RK, Ulbrecht JS, et al. Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle. Am J Physiol Endocrinol Metab 2000; 279 (1): E206-12
152. Hamada K, Vannier E, Sacheck JM, et al. Senescence of human skeletal muscle impairs the local inflammatory cytokine response to acute eccentric exercise. FASEB J 2004; 19 (2): 264-6
153. Chen ZJ. Ubiquitin signalling in the NF-[κ]B pathway. Nat Cell Biol 2005; 7 (8): 758-65
154. Chen ZJ, Bhoj V, Seth RB. Ubiquitin, TAK1 and IKK: is there a connection? Cell Death Differ 2006; 13 (5): 687-92
155. Tergaonkar V, Correa RG, Ikawa M, et al. Distinct roles of I[κ]B proteins in regulating constitutive NF-[κ]B activity. Nat Cell Biol 2005; 7 (9): 921-3
156. Alkalay I, Yaron A, Hatzubai A, et al. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. PNAS 1995; 92 (23): 10599-603
157. Scherer D, Brockman J, Chen Z, et al. Signal-induced degradation of IκBα requires site-specific ubiquitination. PNAS 1995; 92 (24): 11259-63
158. Chen Z, Hagler J, Palombella V, et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Gene Dev 1995; 9 (13): 1586-97
159. Cai D, Frantz JD, Tawa J, et al. IKK[β]/NF-[κ]B activation causes severe muscle wasting in mice. Cell 2004; 119 (2): 285-98
160. Hunter RB, Stevenson E, Koncarevic A, et al. Activation of an alternative NF-κB pathway in skeletal muscle during disuse atrophy. FASEB J 2002; 16 (6): 529-38
161. Kumar A, Boriek AM. Mechanical stress activates the nuclear factor-κB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 2003; 17 (3): 386-96
162. Wyke S, Tisdale M. NF-κB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 2005; 92 (4): 711-21
163. Ji LL, Gomez-Cabrera MC, Steinhafel N, et al. Acute exercise activates nuclear factor (NF)-κB signaling pathway in rat skeletal muscle. FASEB J 2004; 18 (13): 1499-506
164. Ho RC, Hirshman MF, Li Y, et al. Regulation of IμB kinase and NF-κB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 2005; 289 (4): C794-801
165. Durham WJ, Li Y-P, Gerken E, et al. Fatiguing exercise reduces DNA binding activity of NF-κB in skeletal muscle nuclei. J Appl Physiol 2004; 97 (5): 1740-5
166. Murphy LO, MacKeigan JP, Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol 2004; 24 (1): 144-53
167. Simone C, Forcales CS, Hill DA, et al. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004; 36 (7): 738-42
168. Zhao M, New L, Kravchenko VV, et al. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 1999; 19 (1): 21-30
169. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117 (3): 399-412
170. Flück M, Hoppeler H. Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev Physiol Biochem Pharmacol 2003; 146: 159-216
171. Hawley JA. Adaptations of skeletal muscle to prolonged, intense endurance training. Clin Exp Pharmacol Physiol 2002; 29: 218-22
172. Adhihetty PJ, Irrcher I, Joseph AM, et al. Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp Physiol 2003; 88 (1): 99-107
173. Hoppeler H, Flück M. Plasticity of skeletal muscle mitochondria: structure and function. Med Sci Sports Exerc 2003; 35 (1): 95-104
174. Goffart S, Wiesner RJ. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp Physiol 2003; 88 (1): 33-40
175. Hood DA, Irrcher I, Ljubicic V, et al. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 2006; 209 (12): 2265-75
176. Freyssenet D, Irrcher I, Connor MK, et al. Calcium-regulated changes in the mitochondrial phenotype in skeletal muscle cells. Am J Physiol Cell Physiol 2004; 286: C1053-61
177. Gleyzer N, Vercauteren K, Scarpulla RC. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol 2005; 25 (4): 1354-66
178. Scarpulla RC. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002; 286 (1): 81-9
179. Irrcher I, Hood DA. Regulation of Egr-1, SRF, and Sp1 mRNA proliferexpression in contracting skeletal muscle cells. J Appl Physiol 2004; 97 (6): 2207-13
180. Connor MK, Irrcher I, Hood DA. Contractile activity-induced transcriptional activation of cytochrome c involves Sp1 and is proportional to mitochondrial ATP synthesis in C2C12 muscle cells. J Biol Chem 2001; 276 (19): 15898-904
181. Short KR, Vittone JL, Bigelow ML, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003; 52 (8): 1888-96
182. Baar K, Wende AR, Jones TE, et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 2002; 16 (14): 1879-86
183. Scarpulla RC. Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 2006; 97 (4): 673-83
184. Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PG-C-1[α] drives the formation of slow-twitch muscle fibres. Nature 2002; 418 (6899): 797-801
185. Santel A, Fuller M. Control of mitochondrial morphology by a exercishuman mitofusin. J Cell Sci 2001; 114 (5): 867-74
186. Santel A, Frank S, Gaume B, et al. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 2003; 116 (13): 2763-74
187. Bach D, Pich S, Soriano FX, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. J Biol Chem 2003; 278 (19): 17190-7
188. Cartoni R, Leger B, Hock MB, et al. Mitofusins 1/2 and ERRα expression are increased in human skeletal muscle after physical exercise. J Physiol 2005; 567 (1): 349-58
189. Soriano FX, Liesa M, Bach D, et al. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-γ coactivator-1α, estrogen-related receptor-α, and mitofusin 2. Diabetes 2006; 55 (6): 1783-91
190. Kanki T, Ohgaki K, Gaspari M, et al. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol Cell Biol 2004; 24 (22): 9823-34
191. Maniura-Weber K, Goffart S, Garstka HL, et al. Transient overexpression of mitochondrial transcription factor A (TFAM) is sufficient to stimulate mitochondrial DNA transcription, but not sufficient to increase mtDNA copy number in cultured cells. Nucl Acid Res 2004; 32 (20): 6015-27
192. Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98 (1): 115-24
193. Gordon JW, Rungi AA, Inagaki H, et al. Plasticity in skeletal, cardiac and smooth muscle selected contribution: effects of contractile activity on mitochondrial transcription factor A expression in skeletal muscle. J Appl Physiol 2001; 90: 389-96
194. Bengtsson J, Gustafsson T, Widegren U, et al. Mitochondrial transcription factor A and respiratory complex IV increase in response to exercise training in humans. Pflugers Arch 2001; 443 (1): 61-6
195. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000; 20 (5): 1868-76
196. Oberkofler H, Esterbauer H, Linnemayr V, et al. Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity. J Biol Chem 2002; 277 (19): 16750-7
197. Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006; 116 (3): 615-22
198. Lee C-H, Olson P, Evans RM. Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors (minireview). Endocrinology 2003; 144 (6): 2201-7
199. Luquet S, Lopez-Soriano J, Holst D, et al. Peroxisome proliferator-activated receptor-δ controls muscle development and oxidative capability. FASEB J 2003; 17 (15): 2299-301
200. Wang Y, Zhang C, Yu RT, et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004; 2 (10): e294
201. Russell AP, Hesselink MKC, Lo SK, et al. Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB J 2005; 19 (8): 986-8
202. Fritz T, Kramer DK, Karlsson HK, et al. Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev 2006; 22 (6): 492-8
203. Coffey VG, Shield A, Canny BJ, et al. Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes. Am J Physiol Endocrinol Metab 2006; 290 (5): E849-55
204. Norrbom J, Sundberg CJ, Ameln H, et al. PGC-1α mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 2003; 96 (1): 189-94
205. Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcriptional activation of the PGC-1α gene in human skeletal muscle. J Physiol 2003; 546 (3): 851-8
206. Tunstall RJ, Mehan KA, Wadley GD, et al. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 2002; 283: E66-72
207. Pilegaard H, Osada T, Andersen LT, et al. Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. Metabolism 2005; 54 (8): 1048-55
208. Hildebrandt AL, Pilegaard H, Neufer PD. Differential transcriptional activation of select metabolic genes in response to variations in exercise intensity and duration in red and white skeletal muscle. Am J Physiol Endocrinol Metab 2003; 285 (5): E1021-7
209. Phillips SM, Tipton KD, Aarsland A, et al. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol Endocrinol Metab 1997; 36: E99-107
210. Chesley A, MacDougall JD, Tarnopolsky MA, et al. Changes in human muscle protein synthesis after resistance exercise. J Appl Physiol 1992; 73 (4): 1383-8
211. Jones SW, Hill RJ, Krasney PA, et al. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with regulation of skeletal muscle mass. FASEB J 2004; 18 (9): 1025-7
212. Wang X, Li W, Williams M, et al. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 2001; 20 (16): 4370-9
213. Farrell PA, Hernandez JM, Fedele MJ, et al. Eukaryotic initiation factors and protein synthesis after resistance exercise in rats. J Appl Physiol 2000; 88 (3): 1036-42
214. Hannan KM, Brandenburger Y, Jenkins A, et al. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol 2003; 23 (23): 8862-77
215. Musaro A, McCullagh K, Paul A, et al. Localized IGF-1 trans-gene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001; 27 (2): 195-200
216. Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 1998; 84 (5): 1716-22
217. Song YH, Godard M, Li Y, et al. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J Investig Med 2005; 53 (3): 135-42
218. Shen W-H, Boyle DW, Wisniowski P, et al. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J Endocrinol 2005; 185 (2): 275-89
219. Vary TC. IGF-I stimulates protein synthesis in skeletal muscle through multiple signaling pathways during sepsis. Am J Physiol Regul Integr Comp Physiol 2006; 290 (2): R313-21
220. Chakravarthy MV, Abraha TW, Schwartz RJ, et al. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem 2000; 275 (46): 35942-52
221. Jacquemin V, Furling D, Bigot A, et al. IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Exp Cell Res 2004; 299 (1): 148-58
222. Adams GR, Haddad F, Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 1999; 87 (5): 1705-12
223. Adams GR, Cheng DC, Haddad F, et al. Skeletal muscle hypertrophy in response to isometric, lengthening, and shortening training bouts of equivalent duration. J Appl Physiol 2004; 96: 1613-8
224. Hameed M, Orrell RW, Cobbold M, et al. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance training. J Physiol 2003; 547 (1): 247-54
225. Kim J-S, Cross JM, Bamman MM. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 2005; 288 (6): E1110-19
226. Spangenburg EE, Abraha T, Childs TE, et al. Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle and load dependent. Am J Physiol Endocrinol Metab 2002; 284: E340-50
227. Petrella JK, Kim J-S, Cross JM, et al. Efficacy of myonuclear addition may explain differential myofiber growth among resistance trained young and older men and women. Am J Physiol Endocrinol Metab 2006; 291 (5): E937-46
228. Bamman MM, Shipp JR, Jiang J, et al. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 2001; 280 (3): E383-90
229. Psilander N, Damsgaard R, Pilegaard H. Resistance exercise alters MRF and IGF-1 mRNA content in human skeletal muscle. J Appl Physiol 2003; 95: 1038-44
230. Bickel CS, Slade JM, Haddad F, et al. Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects. J Appl Physiol 2003; 94 (6): 2255-62
231. Kostek MC, Delmonico MJ, Reichel JB, et al. Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults. J Appl Physiol 2005; 98 (6): 2147-54
232. MacPherson P, Dennis R, Faulkner J. Sarcomere dynamics and contraction-induced injury to maximally activated single muscle fibres from soleus muscles of rats. J Physiol 1997; 500: 523-80
233. McCully KK, Faulkner JA. Injury to skeletal muscle fibers of mice following lengthening contractions. J Appl Physiol 1985; 59 (1): 119-26
234. Zammit PS, Golding JP, Nagata Y, et al. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J Cell Biol 2004; 166 (3): 347-57
235. Li P, Akimoto T, Zhang M, et al. Resident stem cells are not required for exercise-induced fiber-type switching and angiogenesis but are necessary for activity-dependent muscle growth. Am J Physiol Cell Physiol 2006; 290 (6): C1461-8
236. Ishido M, Kami K, Masuhara M. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying skeletal muscle. Acta Physiol Scand 2004; 180: 281-9
237. Haddad F, Adams GR. Exercise effects on muscle insulin signaling and action: selected contribution: acute cellular and molecular responses to resistance exercise. J Appl Physiol 2002; 93 (1): 394-403
238. Vissing K, Andersen JL, Harridge SDR, et al. Gene expression of myogenic factors and phenotype-specific markers in electrically stimulated muscle of paraplegics. J Appl Physiol 2005; 99 (1): 164-72
239. Kosek DJ, Kim J-S, Petrella JK, et al. Efficacy of 3 D/WK resistance training on myofiber hypertrophy and myogenic mechanisms in young versus older adults. J Appl Physiol 2006; 101 (2): 531-44
240. Siu PM, Donley DA, Bryner RW, et al. Myogenin and oxidative enzyme gene expression levels are elevated in rat soleus muscles after endurance training. J Appl Physiol 2004; 97 (1): 277-85
241. Kadi F, Johansson F, Johansson R, et al. Effects of one bout of endurance exercise on the expression of myogenin in human quadriceps muscle. Histochem Cell Biol 2004; 121: 329-34
242. Reid MB. Response of the ubiquitin-proteasome pathway to changes in muscle activity. Am J Physiol Regul Integr Comp Physiol 2005; 288 (6): R1423-31
243. Du J, Wang X, Miereles C, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004; 113 (1): 115-23
244. Tischler ME, Rosenberg S, Satarug S, et al. Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle. Metabolism 1990; 39 (7): 756-63
245. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18 (1): 39-51
246. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294 (5547): 1704-8
247. Kandarian S, Jackman R. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 2006; 33 (2): 155-65
248. Tintignac LA, Lagirand J, Batonnet S, et al. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 2005; 280 (4): 2847-56
249. Gomes MD, Lecker SH, Jagoe RT, et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. PNAS 2001; 98 (25): 14440-5
250. Wagner KR, Liu X, Chang X, et al. Muscle regeneration in the prolonged absence of myostatin. PNAS 2005; 102 (7): 2519-24
251. McNally EM. Powerful genes: myostatin regulation of human muscle mass. N Engl J Med 2004; 350 (26): 2642-4
252. Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross hypertrophy in a child. N Engl J Med 2004; 350: 2682-8
253. McPherron AC, Lee S-J. Double muscling in cattle due to mutations in the myostatin gene. PNAS 1997; 94 (23): 12457-61
254. Reisz-Porszasz S, Bhasin S, Artaza JN, et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific over expression of myostatin. Am J Physiol Endocrinol Metab 2003; 285: E876-88
255. Langley B, Thomas M, Bishop A, et al. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002; 277 (51): 49831-40
256. McCroskery S, Thomas M, Maxwell L, et al. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003; 162 (6): 1135-47
257. Lee S-J, McPherron AC. Regulation of myostatin activity and muscle growth. PNAS 2001; 98 (16): 9306-11
258. Sandri M, Podhorska-Okolow M, Geromel V, et al. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 1997; 56 (1): 45-57
259. Stupka N, Tarnopolsky MA, Yardley NJ, et al. Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol 2001; 91 (4): 1669-78
260. Willoughby DS, Taylor M, Taylor L. Glucocorticoid receptor and ubiquitin expression after repeated eccentric exercise. Med Sci Sports Exerc 2003; 35 (12): 2023-31
261. Yang Y, Jemiolo B, Trappe SW. Proteolytic mRNA expression in response to acute resistance exercise in human single skeletal muscle fibers. J Appl Physiol 2006; 101 (5): 1442-50
262. Dupont-Versteegden EE, Fluckey JD, Knox M, et al. Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult rats. J Appl Physiol 2006; 101 (1): 202-12
263. Roth SM, Martel GF, Ferrell RE, et al. Myostatin gene expression is reduced in humans with heavy-resistance strength training. Exp Biol Med 2003; 228: 706-9
264. Raue U, Slivka D, Jemiolo B, et al. Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women. J Appl Physiol 2006; 101 (1): 53-9
265. Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 2004; 36 (4): 574-82
266. Matsakas A, Friedel A, Hertrampf T, et al. Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat. Acta Physiol Scand 2005; 183 (3): 299-307
267. Leveritt MD, Abernethy PJ, Barry BK, et al. Concurrent strength and endurance training: a review. Sports Med 1999; 28 (6): 413-27
268. Hickson RC. Interference of strength development by simultaneously training for strength and endurance. Eur J Appl Physiol Occup Physiol 1980; 45: 255-63
269. Hood DA. Plasticity in skeletal, cardiac, and smooth muscle invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 2001; 90: 1137-57
270. Riedy M, Moore RL, Gollnick PD. Adaptive response of hypertrophied skeletal muscle to endurance training. J Appl Physiol 1985; 59 (1): 127-31
271. Stone J, Brannon T, Haddad F, et al. Adaptive responses of hypertrophying skeletal muscle to endurance training. J Appl Physiol 1996; 81 (2): 665-72
272. Putman C, Xu X, Gillies E, et al. Effects of strength, endurance and combined training on myosin heavy chain content and fibre-type distribution in humans. Eur J Appl Physiol 2004; 92 (4-5): 376-84
273. Browne GJ, Proud CG. Regulation of peptide-chain elongation in mammalian cells. Eur J Biochem 2002; 269 (22): 5360-8
274. Ryazanov AG. Ca2+/calmodulin-dependent phosphorylation of elongation factor 2. FEBS Lett 1987; 214 (2): 331-4
275. Horman S, Browne GJ, Krause U, et al. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 2002; 12 (16): 1419-23
276. Rose AJ, Broholm C, Kiillerich K, et al. Exercise rapidly increases eukaryotic elongation factor 2 phosphorylation in skeletal muscle of men. J Physiol (Lond) 2005; 569 (1): 223-8
277. Browne GJ, Proud CG. A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol 2004; 24 (7): 2986-97
278. Daitoku H, Yamagata K, Matsuzaki H, et al. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 2003; 52 (3): 642-9
279. Matsuzaki H, Daitoku H, Hatta M, et al. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. PNAS 2003; 100 (20): 11285-90
280. Southgate RJ, Bruce CR, Carey AL, et al. PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. FASEB J 2005; 19 (14): 2072-4
281. Hoffman EP, Nader GA. Balancing muscle hypertrophy and atrophy. Nat Med 2004; 10 (6): 584-5